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Cutaneous Microdialysis: Is it Worth 
the Sweat?
Chris D. Anderson1
Microdialysis is a minimally invasive technique for chronological study of met-
abolic, biochemical, and pharmacological events in living tissue. In the skin, 
probes are placed in the dermis or subcutis for research in two main areas, 
percutaneous penetration and various aspects of inflammation. Advances in 
technique, and the concept of data generation and analysis are leading to 
new areas of application.
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In our textbooks of dermatology and 
research journals, the comparatively 
little space given to disorders of sweat 
glands does not necessarily corre-
late to the importance assigned to 
abnormal sweating by our patients. 
Classically, we recognize loss or com-
promised function — sweat can be 
absent, diminished, or heightened. 
Hyperhidrosis, for example, can be 
absolutely debilitating in its worst form, 
and anhidrosis can diminish a patient’s 
autonomy and under certain circum-
stances even be life threatening. In this 
issue, Morgan et al. (2006) report find-
ings from in vivo, human experimental 
stimulation of sweating by pharma-
cologically active agents over several 
hours. The article demonstrates a sus-
tained sweating response in the skin 
of healthy volunteers in response to 
delivery of the muscarinic agonist pilo-
carpine nitrate and a reduction when 
atropine sulphate, an antagonist, was 
administered. Simultaneous adminis-
tration of the atropine and the pilocar-
pine blocked the pilocarpine-induced 
sweating completely.
Central to the methodology of 
the article are two bioengineering 
methods. The first is evaporimetry, 
the classic dermatological bioengi-
neering innovation (Nilsson, 1977). 
Evaporimetry was designed to quan-
titate skin barrier function noninva-
sively, and indeed this is its chief use, 
but what was an artifact (water vapor 
that came from sweat glands rather 
than across the stratum corneum) to 
be avoided in a skin barrier function 
experiment becomes a useful quan-
tification of sweat gland production 
in research on sweating. The abil-
ity to quantitate changes in sweating 
noninvasively has obviated the use of 
classical but awkward methods such 
as sweat pads, sweat droplet visu-
alization, and microcannulation. An 
additional advantage is that the meas-
urement can be performed repeatedly 
without preventing or interfering with 
the conduct of the experiment, which 
documents the chronology of the proc-
ess under study. The second method, 
which made possible the protocol of 
Morgan et al. (2006), is, at least in its 
human use, a more recent innovation 
— cutaneous microdialysis. Though 
minimally invasive, it has an increas-
ingly useful place in the bioengineer-
ing armamentarium now available to 
the dermatological scientist.
The basic concept of microdialy-
sis is to mimic the movement of mol-
ecules into and out of a small blood 
vessel by placing a thin tubular dialy-
sis membrane, similar to that used in 
artificial kidneys, into a living tissue. 
The tubular membrane is connected 
to a pump and perfused at low speeds 
with a physiological solution (the per-
fusate), which equilibrates with the 
interstitial fluid outside the membrane 
by diffusion of molecules across the 
membrane in both directions. The 
emerging fluid (the dialysate) is then 
analyzed for the endogenous or exog-
enous compound of interest. In broad 
terms, use of microdialysis technique 
to date has been in three possible sce-
narios: continual, real-time data col-
lection aimed at reflecting whole-body 
status as an alternative to repeated 
blood sampling; organ-specific data 
generation without a direct parallel in 
time or degree to whole-body status; 
and a combination of the aforemen-
tioned, where the researcher’s tech-
nique and ingenuity must separate 
one from the other. The usefulness of 
microdialysis is in the measurement of 
change — to date, more often change 
provoked by spontaneous events (such 
as metabolic deterioration in an inten-
sive care patient) or by the local or 
systemic administration of a provoking 
agent (in the study of inflammation or 
xenobiotic kinetics), but also, increas-
ingly, change provoked by admin-
istration of the active agent via the 
microdialysis catheter itself.
Microdialysis has its origins in ani-
mal research chiefly in neuropharma-
cological models, but catheters have 
been inserted into many human organs, 
including the skin, muscle, brain, 
breast, bone, and gastrointestinal tract. 
The most common organ, however, is 
the skin, with placement either in the 
dermis or in the subcutis. Although 
I feel a certain loyalty to the concept 
that microdialysis was first used der-
matologically to measure percutane-
ous penetration (Anderson et al., 1991) 
with probes placed in the dermis, the 
plain fact is that the very first publica-
tions involved placement of catheters 
into the subcutis in order to study glu-
cose metabolism (Jansson et al., 1988; 
Arner et al., 1988). These studies and 
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those that followed have changed our 
concept of the subcutis and its com-
plex function. Indeed, also in the field 
of percutaneous penetration, the tech-
nique has increased our knowledge 
of the mechanisms of both local and 
systemic drug delivery and skin barrier 
function as it applies to living human 
skin in both human (Benfeldt et al., 
1999; Muller, 2000) and experimental 
model applications (Ault et al., 1992; 
Simonsen et al., 2004).
The technique is not without its 
technical challenges. Microdialysis 
research projects begin with the choice 
of a dialysis membrane through which 
a target molecule is able to permeate; 
the porosity of a membrane is usu-
ally described in terms of its molecu-
lar weight “cutoff.” The most common 
membrane has a 20-kilodalton cutoff, 
though the most efficient movement is 
obtained for molecules of much lower 
molecular weight — ideally only a 
few hundred daltons. Other common 
membrane cutoffs are 100 kilodaltons 
(most effective for molecules less than 
40 kilodaltons) and 3,000 kilodaltons 
(plasmapheresis membranes, useful 
also for molecules over 100 kilodal-
tons). Membranes may have idio-
syncratic interactions with particular 
target molecules based on factors other 
than molecular weight. Catheters are 
available in commercially (validated 
and certified) formats or as “laboratory-
made” constructions. Pumps capable 
of low (0.1–8 microliters per minute) 
and consistent speeds are required. 
The perfusate characteristics may need 
modification to cope with rheostatic, 
water-transport, or other issues more 
closely related to the target molecule. 
The required temporal resolution of 
the experimental protocol needs to be 
considered — microdialysis as a tech-
nique is unnecessary unless change (a 
dynamic process) is to be observed. 
The limits of temporal resolution (in an 
optimal situation, 1–5 minutes) are set 
chiefly by the availability of analytical 
techniques that cope with the low vol-
umes and concentrations inherent to 
microdialysis technique.
Microdialysis requires introduction 
into the tissue by means of a guide 
needle and is thus a “minimally inva-
sive” technique. The self-righteous 
dermatological scientist can be aghast 
at the “black box” mentality some-
times displayed in the use of “our” 
organ for microdialysis, but we all 
need to be reminded, at times, of the 
consequences of catheter insertion 
in any organ. Figure 1 illustrates, in a 
not-to-scale photomicrographic col-
lage of a microdialysis membrane on 
a slightly inflamed dermis, some of the 
issues that must be considered in the 
interpretation of data from analysis of 
the catheter microdialysate (the issues 
being generic for all microdialysis 
applications). The insertion reaction 
in the skin is both obvious and easy 
to quantitate (Andersson et al., 1995), 
but recovery occurs and subsequent 
provocation can be studied. Usually 
a tissue, including the skin, can be 
expected to return to a near-baseline 
level after about 1 hour. After this time 
it is expected that values observed in 
the dialysate will reflect the concen-
tration of a target agent in the inter-
stitial fluid. But this will only be so 
in absolute terms if the measured raw 
value in the dialysate is adjusted by 
consideration of various aspects of 
the recovery of the molecule of inter-
est, under the relevant circumstances 
of the experiment. This demands thor-
ough knowledge of basic tissue sci-
ence at a general and an organ level, 
with a focus on vascular and neuro-
genic reactivity as well as factors such 
as edema that affect molecular move-
ment in a tissue. The experimental 
design needs to consider these mat-
ters and propose a “recovery” figure 
or a rationale for the use of raw data 
according to a number of now well-
tried alternatives.
Despite the above-mentioned tech-
nical, conceptual, and data-interpre-
tive challenges, microdialysis remains 
unique in the opportunities it offers 
for observation of what happens in 
the actual microenvironment of a 
tissue, including its cells and more 
amorphous components. Histamine, 
a small molecule that is relatively 
easy to analyze, was the first focus on 
the inflammatory side of cutaneous 
microdialysis research (Petersen et al., 
1995; Krogstad et al., 1997), but the 
perfused hollow fiber can allow meas-
urement of many substances in the 
dermis, including protein exudation, 
which has led to many papers on neu-
rophysiological mechanisms (Ikoma et 
al., 2004). Other aspects of “cell talk” 
are also becoming accessible through 
improved analytical techniques, for 
example for cytokines (Sjögren et al., 
2002). Studies of diseased skin are 
possible with due attention to study 
Figure 1. Microdialysis at a tissue level. Not-to-
scale collage of photomicrographs showing a 
tubular microdialysis membrane and a section 
of dermis into which it could be placed. Cin 
represents the concentration of a target molecule 
measured in the microdialysate. The molecule 
can be present in the dermis (endogenous or 
exogenous) or can be a molecule in the perfusate 
(a banal molecule, a calibrator, or a drug to be 
administered). Cout represents the concentration 
of the target substance immediately outside the 
membrane; the level will be determined by a 
number of factors, such as the characteristics 
of the molecule and the membrawne, any 
interaction between the molecule and the 
membrane, and the concentration gradient 
across the membrane, as well as the pumping 
speed of the perfusate. The sum of these effects 
can be seen as the efficiency of transport over 
the membrane and is bidirectional (recovery or 
loss). C represents the concentration of the target 
molecule in the tissue at some distance from the 
membrane; derivation of this figure (the actual 
aim of the microdialysis procedure) can involve 
complex modeling of the process. Though the 
microdialysis catheter is placed as an imitation of 
a blood vessel, it is of course unable to react as 
a vessel does; the two are in fact in competition 
for distribution of a target substance. S represents 
a potential “sink” or “supply” via blood vessels 
that will affect C. The innate diffusion process 
of the target molecule in the tissue (devoid of 
blood flow influence) is represented by D. It is 
relevant because a target molecule diffusing into 
the microdialysate must be replaced by diffusion 
through the tissue if subsequent microdialysis 
measurements are not to be artificially low 
because of a lowered concentration gradient 
across the membrane. Thus S and D will affect 




design including internal normal skin 
controls. Developments in other spe-
cialties are also showing us the way 
for broader use, for instance in the 
study of tumors (Dabrosin, 2005).
Writing a Commentary such as this 
can make the author feel challenged 
— “So much to do (refer to) and so 
little time (column space).” Read the 
article by Morgan et al.(2006); fol-
low the trail provided by the sub-
jects and authors referred to there 
and in this commentary. It will lead 
you to around 500 articles involving 
microdialysis and skin, around 3,000 
articles on human microdialysis in 
a wide range of organs and applica-
tions, and a total microdialysis bibli-
ography approaching 10,000 articles. 
Think broadly about the opportunities 
offered by cutaneous microdialysis for 
application in your own special area 
of research. You will very likely find it 
worth the sweat!
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The Skin as a Site of Initiation of 
Systemic Autoimmune Disease: New 
Opportunities for Treatment
Jan P. Dutz1,2
Dendritic cells are the coordinators of the adaptive immune response. Chronic 
activation of skin dendritic cells by keratinocyte expression of CD40 ligand 
(CD40L; CD154) leads to autoimmunity. In this issue, systemic administration of 
tacrolimus is shown by Loser et al. to effectively treat autoimmunity in a murine 
model involving transgenic keratinocyte expression of CD40L.
Journal of Investigative Dermatology (2006) 126, 1209–1212. doi:10.1038/sj.jid.5700238
Chronic skin dendritic-cell activation 
and autoimmunity
Over the past 20 years, dendritic cells 
have become recognized as the prime 
orchestrators of the adaptive immune 
response (Banchereau and Steinman, 
1998). These cells most efficiently acti-
vate or prime T cells (Inaba et al., 1990). 
More recently, their dual role as inhibi-
tory regulators of the immune response 
has been appreciated (Hawiger et al., 
2001). For example, Langerhans cells, 
long thought to be proinflammatory 
sentinels, have been shown to be dis-
pensable for the cutaneous (Allan et al., 
2003) or mucosal (Zhao et al., 2003) 
priming of cytotoxic T cells to herpes 
simplex virus and to have a potentially 
suppressive role in contact hypersen-
sitivity responses (Kaplan et al., 2005). 
With this dual role, dendritic cells are 
probably key players in the march to 
autoimmunity.
Proinflammatory stimulation of 
dendritic cells with activation signals 
such as Toll-like receptors (Iwasaki and 
Medzhitov, 2004) or CD40 ligation 
(Ridge et al., 1998) results in the matu-
ration of dendritic cells and subsequent 
efficient T-cell activation. Chronic den-
dritic-cell stimulation may result in an 
autoimmune phenotype. For example, 
1Departments of Dermatology and Medicine and Child & Family Research Institute, University of British 
Columbia, Vancouver, British Columbia, Canada; and 2Division of Rheumatology, Department of Medi-
cine and Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia, 
Canada
Correspondence: Dr. Jan P. Dutz, Department of Medicine and Child & Family Research Institute, 
University of British Columbia, 301-835 W. 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E8. 
E-mail: dutz@interchange.ubc.ca
